(Q41567132)

3 October 2017

1 reference

title

Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy (English)

1 reference

3 October 2017

3

R Champlin

1 reference

3 October 2017

1

K van Besien

1 reference

3 October 2017

A Forman

2

1 reference

3 October 2017

language of work or name

1 reference

1 June 1997

1 reference

3 October 2017

1 reference

3 October 2017

volume

8

1 reference

3 October 2017

issue

6

1 reference

3 October 2017

page(s)

515-524

1 reference

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Delayed central nervous system (CNS) radiation in childhood CNS acute lymphoblastic leukemia. Results of a pilot trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

CNS leukemia: problem of diagnosis, treatment, and outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Central Nervous System Involvement in Patients with Diffuse Aggressive Non-Hodgkinʼs Lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

CNS involvement in the non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Techniques of magna-field irradiation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Distribution and pharmacokinetics of cyclophosphamide in the rat

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

An experimental model for meningeal leukemia in rats (L5222). Effect of treatment with BCNU and cyclophosphamide.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

High-dose intravenous melphalan: a review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyU-l-nitrosourea (BCNU) in man and animals

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Concentrations of VP16 and VM26 in human brain tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Pharmacokinetics of high-dose melphalan in children and adults

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

A phase II trial of oral melphalan in recurrent primary brain tumors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

The systemic administration of intravenous melphalan

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Syndrome of inappropriate antidiuretic hormone secretion. A complication of high-dose intravenous melphalan

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Neurologic complications of bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Subacute panencephalitis associated with chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Cranial nerve involvement in children with leukemia and lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Involvement of the central nervous system in non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Effects of ionizing radiation on the blood brain barrier permeability to pharmacologically active substances

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Allogeneic blood stem cell transplantation in advanced hematologic cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Platinum Concentrations in Human Autopsy Tumor Samples

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Treatment of astrocytoma with a 5-day cisplatin infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Remission induction of meningeal leukemia with high-dose intravenous methotrexate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008248315859

7 January 2021

Identifiers

DOI

10.1023/A:1008248315859

1 reference

3 October 2017

1 reference